abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month High – Should You Buy?

abrdn Healthcare Investors (NYSE:HQH) hit a new 52-week high on Thursday . The stock traded as high as $19.73 and last traded at $19.7250, with a volume of 74650 shares changing hands. The stock had previously closed at $19.44.

abrdn Healthcare Investors Price Performance

The company has a 50 day moving average price of $19.01 and a 200 day moving average price of $17.81.

abrdn Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, January 12th. Shareholders of record on Friday, November 21st were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 11.6%. This is a boost from abrdn Healthcare Investors’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Friday, November 21st.

Hedge Funds Weigh In On abrdn Healthcare Investors

A number of large investors have recently modified their holdings of the company. Flagship Harbor Advisors LLC acquired a new stake in abrdn Healthcare Investors in the 4th quarter valued at $48,000. Uhlmann Price Securities LLC lifted its stake in shares of abrdn Healthcare Investors by 3.1% in the fourth quarter. Uhlmann Price Securities LLC now owns 25,711 shares of the financial services provider’s stock valued at $487,000 after buying an additional 781 shares in the last quarter. Advisory Services Network LLC acquired a new position in shares of abrdn Healthcare Investors during the third quarter valued at about $97,000. NewEdge Advisors LLC grew its holdings in shares of abrdn Healthcare Investors by 130.2% during the third quarter. NewEdge Advisors LLC now owns 101,586 shares of the financial services provider’s stock valued at $1,875,000 after buying an additional 57,456 shares during the last quarter. Finally, Triumph Capital Management increased its position in shares of abrdn Healthcare Investors by 3.2% during the third quarter. Triumph Capital Management now owns 46,442 shares of the financial services provider’s stock worth $857,000 after acquiring an additional 1,443 shares in the last quarter. 32.60% of the stock is currently owned by institutional investors.

About abrdn Healthcare Investors

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.